X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1392) 1392
Book Review (330) 330
Publication (151) 151
Magazine Article (13) 13
Book / eBook (6) 6
Book Chapter (6) 6
Conference Proceeding (2) 2
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1330) 1330
index medicus (1257) 1257
male (889) 889
female (885) 885
middle aged (716) 716
oncology (587) 587
aged (559) 559
oropharyngeal cancer (558) 558
adult (541) 541
cancer (482) 482
head (447) 447
squamous-cell carcinoma (409) 409
risk factors (358) 358
human papillomavirus (347) 347
neck-cancer (315) 315
head and neck cancer (295) 295
oropharyngeal neoplasms - virology (290) 290
otorhinolaryngology (287) 287
papillomavirus infections (277) 277
surgery (275) 275
squamous cell carcinoma (273) 273
radiotherapy (255) 255
aged, 80 and over (234) 234
oropharyngeal neoplasms - epidemiology (220) 220
oropharyngeal neoplasms - pathology (210) 210
united-states (210) 210
carcinoma, squamous cell - virology (203) 203
papillomavirus infections - complications (200) 200
dentistry, oral surgery & medicine (195) 195
prognosis (195) 195
incidence (194) 194
care and treatment (192) 192
research (189) 189
retrospective studies (189) 189
human-papillomavirus (187) 187
analysis (182) 182
health aspects (178) 178
prevalence (178) 178
epidemiology (177) 177
survival (173) 173
carcinoma, squamous cell - pathology (172) 172
papillomavirus infections - epidemiology (170) 170
hematology, oncology and palliative medicine (163) 163
papillomavirus infections - virology (163) 163
treatment outcome (163) 163
hpv (161) 161
dentistry (158) 158
neoplasm staging (156) 156
oropharyngeal neoplasms - prevention & control (153) 153
oropharyngeal neoplasms - radiotherapy (151) 151
neck (150) 150
oral cancer (141) 141
chemotherapy (134) 134
prevention (132) 132
young adult (132) 132
adolescent (130) 130
article (130) 130
risk (130) 130
papillomavirus infections - prevention & control (129) 129
quality-of-life (128) 128
head and neck neoplasms - virology (127) 127
smoking (127) 127
oropharyngeal neoplasms - therapy (124) 124
oropharyngeal neoplasms - mortality (122) 122
radiology, nuclear medicine & medical imaging (120) 120
carcinoma, squamous cell - epidemiology (119) 119
oropharyngeal neoplasms - surgery (119) 119
infection (116) 116
throat cancer (114) 114
diagnosis (113) 113
prospective studies (110) 110
head & neck cancer (109) 109
abridged index medicus (106) 106
case-control studies (106) 106
tumors (106) 106
otolaryngology (105) 105
follow-up studies (104) 104
head and neck neoplasms - radiotherapy (104) 104
papillomaviruses (103) 103
radiation-therapy (103) 103
mouth neoplasms - epidemiology (101) 101
papillomaviridae - isolation & purification (97) 97
public, environmental & occupational health (97) 97
squamous cell carcinoma of head and neck (96) 96
carcinoma, squamous cell - mortality (95) 95
carcinoma, squamous cell - radiotherapy (95) 95
radiotherapy dosage (95) 95
carcinoma, squamous cell - therapy (94) 94
head and neck neoplasms - pathology (94) 94
risk-factors (94) 94
radiation (93) 93
cervical cancer (92) 92
patients (90) 90
survival rate (89) 89
trends (89) 89
carcinoma, squamous cell - surgery (88) 88
survival analysis (88) 88
medicine & public health (87) 87
oropharynx (86) 86
cohort studies (85) 85
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1368) 1368
German (14) 14
French (12) 12
Russian (4) 4
Danish (3) 3
Hungarian (3) 3
Japanese (3) 3
Italian (2) 2
Dutch (1) 1
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 02/2013, Volume 105, Issue 3, pp. 175 - 201
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American... 
United States - epidemiology | Age Distribution | Asian Americans - statistics & numerical data | Humans | Uterine Cervical Neoplasms - epidemiology | Cost of Illness | Anus Neoplasms - virology | Hispanic Americans - statistics & numerical data | Male | Neoplasms - prevention & control | Cause of Death | Incidence | Indians, North American - statistics & numerical data | Penile Neoplasms - epidemiology | Neoplasms - virology | Neoplasms - ethnology | Female | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - virology | Papillomavirus Infections - complications | SEER Program | Papanicolaou Test | Papillomavirus Infections - epidemiology | Neoplasms - mortality | Papillomavirus Infections - ethnology | Vulvar Neoplasms - virology | Mortality - trends | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Vaginal Smears - statistics & numerical data | Alphapapillomavirus | Oropharyngeal Neoplasms - epidemiology | African Americans - statistics & numerical data | Oceanic Ancestry Group - statistics & numerical data | Vaginal Neoplasms - epidemiology | Adolescent | Vulvar Neoplasms - epidemiology | Sex Distribution | Uterine Cervical Neoplasms - virology | Neoplasms - epidemiology | Prevention | Control | Forecasts and trends | Papillomavirus infections | Patient outcomes | Mortality | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/2015, Volume 107, Issue 6, pp. djv086 - djv086
Background: This study sought to determine the prevaccine type-specific prevalence of human papillomavirus (HPV)-associated cancers in the United States to... 
UNITED-STATES | HUMAN-PAPILLOMAVIRUS TYPES | WORLDWIDE | IMPACT | ATTRIBUTION | ONCOLOGY | INVASIVE CERVICAL-CANCER | INFECTION | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | VACCINATION COVERAGE | United States - epidemiology | Humans | Middle Aged | DNA, Viral - isolation & purification | Male | Neoplasms - prevention & control | Alphapapillomavirus - isolation & purification | Neoplasms - virology | Human papillomavirus 16 - isolation & purification | Adult | Female | Papillomavirus Infections - virology | Registries | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - virology | Papillomavirus Infections - complications | Penile Neoplasms - prevention & control | Uterine Cervical Neoplasms - prevention & control | Vulvar Neoplasms - virology | Oropharyngeal Neoplasms - virology | Laryngeal Neoplasms - prevention & control | Human papillomavirus 18 - isolation & purification | Alphapapillomavirus - genetics | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Uterine Cervical Neoplasms - virology | Oropharyngeal Neoplasms - prevention & control | Papillomavirus Vaccines - immunology | Aged | Laryngeal Neoplasms - virology | Papillomaviruses | Causes of | Genetic aspects | Health aspects | Identification and classification | Cancer | Human papillomavirus | Demographics | Vaccines | Medical diagnosis | Index Medicus
Journal Article
Head & Neck, ISSN 1043-3074, 12/2012, Volume 34, Issue 12, pp. 1681 - 1703
Journal Article
Vaccine, ISSN 0264-410X, 11/2017, Volume 35, Issue 46, pp. 6329 - 6335
Estonia has high cervical cancer incidence and low screening coverage. We modelled the impact of population-based bivalent, quadrivalent or nonavalent HPV... 
Genital warts | Cost-effectiveness | Vaccination | Cervical cancer | HPV | MEDICINE, RESEARCH & EXPERIMENTAL | COUNTRIES | IMMUNOLOGY | WOMEN | TRANSMISSION | MEN | INFECTION | BURDEN | HUMAN-PAPILLOMAVIRUS-VACCINATION | QUADRIVALENT | VACCINES | Estonia - epidemiology | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Incidence | Young Adult | Vaginal Neoplasms - prevention & control | Aged, 80 and over | Uterine Cervical Neoplasms - economics | Adult | Female | Anus Neoplasms - epidemiology | Oropharyngeal Neoplasms - economics | Child | Papillomavirus Vaccines - administration & dosage | Mouth Neoplasms - prevention & control | Papillomavirus Infections - complications | Papillomavirus Vaccines - economics | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Mouth Neoplasms - economics | Models, Statistical | Mouth Neoplasms - epidemiology | Oropharyngeal Neoplasms - epidemiology | Vaginal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Cost-Benefit Analysis | Adolescent | Vaginal Neoplasms - economics | Oropharyngeal Neoplasms - prevention & control | Papillomavirus Vaccines - immunology | Aged | Anus Neoplasms - economics | Medical research | Analysis | Medicine, Experimental | Diagnosis | Cancer | Health insurance | Immunization | Sensitivity analysis | Mortality | Vagina | Infections | Vaccines | Cervix | Cost benefit analysis | Medical screening | Immunity | Girls | Cancer vaccines | Warts | Screening | Human papillomavirus | Utilities | Markov models | Lesions | Index Medicus
Journal Article
Sexually Transmitted Infections, ISSN 1368-4973, 11/2012, Volume 88, Issue 7, pp. 517 - 521
Objectives To obtain health-related quality of life valuations (ie, utilities) for human papillomavirus (HPV)-related cancer health states of vulval, vaginal,... 
UNITED-STATES | HEAD | INFECTIOUS DISEASES | LONG-TERM SURVIVORS | OROPHARYNX | MANAGEMENT | SQUAMOUS-CELL CARCINOMA | RADIOTHERAPY | BURDEN | NECK-CANCER | EPIDEMIOLOGY | Vaginal Neoplasms - psychology | Humans | Middle Aged | Anus Neoplasms - prevention & control | Anus Neoplasms - virology | Male | Oropharyngeal Neoplasms - psychology | Oropharyngeal Neoplasms - pathology | Anus Neoplasms - psychology | Young Adult | Vulvar Neoplasms - pathology | Penile Neoplasms - pathology | Penile Neoplasms - psychology | Vaginal Neoplasms - prevention & control | Adult | Female | Surveys and Questionnaires | Penile Neoplasms - virology | Papillomavirus Infections - complications | Penile Neoplasms - prevention & control | Vaginal Neoplasms - pathology | Vulvar Neoplasms - virology | Anus Neoplasms - pathology | Oropharyngeal Neoplasms - virology | Patient Acceptance of Health Care - statistics & numerical data | Health Knowledge, Attitudes, Practice | Vaginal Neoplasms - virology | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Adolescent | Quality of Life | Oropharyngeal Neoplasms - prevention & control | Aged | Vulvar Neoplasms - psychology | Papillomaviruses | Prevention | Causes of | Host-virus relationships | Health aspects | Papillomavirus infections | Risk factors | Quality of life | Studies | Human papillomavirus | Cervical cancer | Index Medicus | oral sex | attitudes | oral cavity | Anogenital cancer | Health Services Research | 1506 | oncology | HPV | vaccination
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 42, pp. 6016 - 6019
Highlights ► We estimated the annual direct medical costs attributable to HPV in the USA. ► The overall annual direct medical cost burden was estimated to be... 
Allergy and Immunology | Genital warts | Human papillomavirus | Health economics | Intraepithelial neoplasia | Cost | Vulvar, vaginal, anal, oral cavity, oropharyngeal, and cervical cancer | MEDICINE, RESEARCH & EXPERIMENTAL | POPULATION | IMMUNOLOGY | US HEALTH PLAN | CANCER SCREENING RATES | IMPACT | RECURRENT RESPIRATORY PAPILLOMATOSIS | HPV VACCINE | BURDEN | BENEFITS | Early Detection of Cancer - economics | United States - epidemiology | Papillomavirus Vaccines - economics | Humans | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - epidemiology | Respiratory Tract Infections - prevention & control | Uterine Cervical Neoplasms - prevention & control | Condylomata Acuminata - epidemiology | Cost of Illness | Respiratory Tract Infections - economics | Condylomata Acuminata - prevention & control | Papillomavirus Infections - economics | Oropharyngeal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Health Care Costs - statistics & numerical data | Uterine Cervical Neoplasms - economics | Condylomata Acuminata - economics | Female | Oropharyngeal Neoplasms - prevention & control | Oropharyngeal Neoplasms - economics | Respiratory Tract Infections - epidemiology | Prevention | Warts | Papillomaviruses | Sexually transmitted diseases | Oncology, Experimental | Research | Papillomavirus infections | Cervical cancer | Cancer | Medical care, Cost of | Vaccines | Medical screening | Womens health | Index Medicus | Economics | Penis | Vaccination | Vagina | Papilloma | oropharyngeal cancer | Anogenital | genital warts | cost | intraepithelial neoplasia | vulvar | anal | oral cavity | vaginal | health economics
Journal Article
Sexual Health, ISSN 1448-5028, 2010, Volume 7, Issue 3, pp. 244 - 252
Although the human papillomavirus (HPV) vaccine was introduced primarily as a cervical cancer prevention vaccine, HPV has a causal role in several types of... 
Australia | HPV vaccine | cervical cancer | UNITED-STATES | INFECTIOUS DISEASES | METAANALYSIS | PREVENTION | CERVICAL-CANCER | PREVALENCE | INTRAEPITHELIAL NEOPLASIA | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ANAL CANCER | SEXUAL PRACTICES | SQUAMOUS-CELL CARCINOMAS | PENILE CANCER | Age Factors | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Male | Human papillomavirus 18 | Incidence | Penile Neoplasms - epidemiology | Young Adult | Human papillomavirus 16 | Sexually Transmitted Diseases, Viral - epidemiology | Vaginal Neoplasms - prevention & control | Adult | Female | Anus Neoplasms - epidemiology | Cervical Intraepithelial Neoplasia - epidemiology | Child | Papillomavirus Vaccines - administration & dosage | Cross-Sectional Studies | Carcinoma, Squamous Cell - epidemiology | Papanicolaou Test | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Vaginal Smears | Carcinoma, Squamous Cell - prevention & control | Oropharyngeal Neoplasms - epidemiology | Vaginal Neoplasms - epidemiology | Cross-Cultural Comparison | Papillomavirus Infections - prevention & control | Vulvar Neoplasms - prevention & control | Adolescent | Sex Factors | Sexually Transmitted Diseases, Viral - prevention & control | Vulvar Neoplasms - epidemiology | Cervical Intraepithelial Neoplasia - prevention & control | Oropharyngeal Neoplasms - prevention & control | Aged | Developing Countries | Population Surveillance
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2016, Volume 108, Issue 1, p. djv282
Journal Article